KEY MESSAGES

Meibomian gland blockage and resulting meibum stasis in meibomian gland dysfunction (MGD) can lead to a deficiency of critical lipids in the tear film and compromise tear film integrity. According to several committees of clinical experts, the first line and mainstay therapies for MGD are lid hygiene, and heating and expression. While conventional warm compresses have traditionally been recommended, their efficacy varies widely due to poor standardization of regimen and poor compliance by patients.

The Systane iLux emits light energy at two wavelengths to penetrate different depths of the eyelid. Temperature sensors on the anterior and posterior eyelids allows the device to ensure that therapeutic levels of heat are reached and maintained by the eyelids. Subsequent gland expression helps to clear the blockages from the gland ducts. It has shown quick and enduring effects on MGD signs and symptoms.

Systane iLux² offers some of the most advanced technologies for managing MGD patients: same heating technology, touchscreen high-definition screen, photo and video capture with white light, and meibomian gland imaging with infrared light. With a single handheld device, clinicians can visualize, treat, and monitor for changes in meibomian glands of MGD patients.